Annual CFF
$12.45 M
-$4.53 M-26.69%
December 31, 2023
Summary
- As of February 7, 2025, VCNX annual cash flow from financing activities is $12.45 million, with the most recent change of -$4.53 million (-26.69%) on December 31, 2023.
- During the last 3 years, VCNX annual CFF has fallen by -$24.31 million (-66.14%).
- VCNX annual CFF is now -69.61% below its all-time high of $40.95 million, reached on December 31, 2018.
Performance
VCNX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$5.89 M
+$4.20 M+248.40%
September 30, 2024
Summary
- As of February 7, 2025, VCNX quarterly cash flow from financing activities is $5.89 million, with the most recent change of +$4.20 million (+248.40%) on September 30, 2024.
- Over the past year, VCNX quarterly CFF has dropped by -$181.00 thousand (-2.98%).
- VCNX quarterly CFF is now -82.31% below its all-time high of $33.28 million, reached on September 30, 2018.
Performance
VCNX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$18.65 M
+$4.56 M+32.33%
September 30, 2024
Summary
- As of February 7, 2025, VCNX TTM cash flow from financing activities is $18.65 million, with the most recent change of +$4.56 million (+32.33%) on September 30, 2024.
- Over the past year, VCNX TTM CFF has increased by +$2.15 million (+13.06%).
- VCNX TTM CFF is now -66.21% below its all-time high of $55.19 million, reached on March 31, 2021.
Performance
VCNX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VCNX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.7% | -3.0% | +13.1% |
| 3 y3 years | -66.1% | +191.3% | +222.3% |
| 5 y5 years | -69.6% | +191.3% | +222.3% |
VCNX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.6% | at low | -55.4% | >+9999.0% | -20.1% | +222.3% |
| 5 y | 5-year | -66.1% | at low | -77.3% | +328.7% | -66.2% | +222.3% |
| alltime | all time | -69.6% | at low | -82.3% | +328.7% | -66.2% | +368.6% |
Vaccinex Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.89 M(+248.4%) | $18.65 M(+32.3%) |
| Jun 2024 | - | $1.69 M(-72.2%) | $14.09 M(-14.6%) |
| Mar 2024 | - | $6.07 M(+21.4%) | $16.49 M(+32.5%) |
| Dec 2023 | $12.45 M(-26.7%) | $5.00 M(+275.4%) | $12.45 M(+10.7%) |
| Sep 2023 | - | $1.33 M(-67.4%) | $11.25 M(+13.7%) |
| Jun 2023 | - | $4.09 M(+102.5%) | $9.90 M(+71.0%) |
| Mar 2023 | - | $2.02 M(-46.8%) | $5.79 M(-65.9%) |
| Dec 2022 | $16.98 M(-27.2%) | $3.80 M(<-9900.0%) | $16.98 M(+29.0%) |
| Sep 2022 | - | -$19.00 K(+5.6%) | $13.16 M(+24.1%) |
| Jun 2022 | - | -$18.00 K(-100.1%) | $10.61 M(-0.2%) |
| Mar 2022 | - | $13.21 M(<-9900.0%) | $10.63 M(-54.4%) |
| Dec 2021 | $23.32 M(-36.5%) | -$9000.00(-99.7%) | $23.32 M(+0.5%) |
| Sep 2021 | - | -$2.58 M(<-9900.0%) | $23.22 M(-55.1%) |
| Jun 2021 | - | $0.00(-100.0%) | $51.70 M(-6.3%) |
| Mar 2021 | - | $25.91 M(<-9900.0%) | $55.19 M(+50.1%) |
| Dec 2020 | $36.76 M | -$115.00 K(-100.4%) | $36.76 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $25.91 M(+643.9%) | $36.87 M(+48.9%) |
| Jun 2020 | - | $3.48 M(-53.4%) | $24.76 M(+16.4%) |
| Mar 2020 | - | $7.48 M(>+9900.0%) | $21.28 M(+54.2%) |
| Dec 2019 | $13.80 M(-66.3%) | $0.00(-100.0%) | $13.80 M(0.0%) |
| Sep 2019 | - | $13.80 M(>+9900.0%) | $13.80 M(-58.5%) |
| Jun 2019 | - | $0.00(0.0%) | $33.28 M(-10.1%) |
| Mar 2019 | - | $0.00(0.0%) | $37.00 M(-9.7%) |
| Dec 2018 | $40.95 M(+70.8%) | $0.00(-100.0%) | $40.95 M(-19.6%) |
| Sep 2018 | - | $33.28 M(+794.1%) | $50.96 M(+135.0%) |
| Jun 2018 | - | $3.72 M(-5.9%) | $21.68 M(-9.5%) |
| Mar 2018 | - | $3.96 M(-60.4%) | $23.95 M(-0.1%) |
| Dec 2017 | $23.97 M(+46.6%) | $10.00 M(+149.8%) | $23.97 M(+71.6%) |
| Sep 2017 | - | $4.00 M(-33.2%) | $13.97 M(+40.2%) |
| Jun 2017 | - | $5.99 M(+50.6%) | $9.97 M(+150.6%) |
| Mar 2017 | - | $3.98 M | $3.98 M |
| Dec 2016 | $16.36 M | - | - |
FAQ
- What is Vaccinex annual cash flow from financing activities?
- What is the all time high annual CFF for Vaccinex?
- What is Vaccinex annual CFF year-on-year change?
- What is Vaccinex quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Vaccinex?
- What is Vaccinex quarterly CFF year-on-year change?
- What is Vaccinex TTM cash flow from financing activities?
- What is the all time high TTM CFF for Vaccinex?
- What is Vaccinex TTM CFF year-on-year change?
What is Vaccinex annual cash flow from financing activities?
The current annual CFF of VCNX is $12.45 M
What is the all time high annual CFF for Vaccinex?
Vaccinex all-time high annual cash flow from financing activities is $40.95 M
What is Vaccinex annual CFF year-on-year change?
Over the past year, VCNX annual cash flow from financing activities has changed by -$4.53 M (-26.69%)
What is Vaccinex quarterly cash flow from financing activities?
The current quarterly CFF of VCNX is $5.89 M
What is the all time high quarterly CFF for Vaccinex?
Vaccinex all-time high quarterly cash flow from financing activities is $33.28 M
What is Vaccinex quarterly CFF year-on-year change?
Over the past year, VCNX quarterly cash flow from financing activities has changed by -$181.00 K (-2.98%)
What is Vaccinex TTM cash flow from financing activities?
The current TTM CFF of VCNX is $18.65 M
What is the all time high TTM CFF for Vaccinex?
Vaccinex all-time high TTM cash flow from financing activities is $55.19 M
What is Vaccinex TTM CFF year-on-year change?
Over the past year, VCNX TTM cash flow from financing activities has changed by +$2.15 M (+13.06%)